Carmignac Gestion »

Amicus Therapeutics shares owned by Carmignac Gestion

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Carmignac Gestion from 13F filings

Historical chart of Carmignac Gestion investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Carmignac Gestion consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Carmignac Gestion

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.8M 195k 14.24

More positions owned by Carmignac Gestion

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
S&p Global (SPGI)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
AmerisourceBergen (COR)
McKesson Corporation (MCK)
MercadoLibre (MELI)
salesforce (CRM)
Servicenow (NOW)
Tradeweb Markets Cl A (TW)
Intercontinental Exchange (ICE)
Block Cl A (XYZ)
Atlassian Corp Cl A (TEAM)
SLB Com Stk (SLB)

View all positions for Carmignac Gestion

Top funds holding Amicus Therapeutics

BlackRock
Vanguard Group
Wellington Management Company
State Street Corporation
Millennium Management
Bellevue Group
William Blair Investment Management
Citadel Advisors
Geode Capital Management
Perceptive Advisors
Goldman Sachs Group
UBS Group
Palo Alto Investors
Soleus Capital Management
Soros Fund Management

View all funds holding Amicus Therapeutics